Skip to main content
STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
220.56
-0.23 (-0.10%)
Feb 21, 2025, 4:00 PM EST - Market closed

STERIS Revenue

STERIS had revenue of $1.37B in the quarter ending December 31, 2024, with 5.61% growth. This brings the company's revenue in the last twelve months to $5.40B, up 15.29% year-over-year. In the fiscal year ending March 31, 2024, STERIS had annual revenue of $5.14B with 13.28% growth.

Revenue (ttm)
$5.40B
Revenue Growth
+15.29%
P/S Ratio
4.03
Revenue / Employee
$296,956
Employees
18,179
Market Cap
21.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20245.14B602.44M13.28%
Mar 31, 20234.54B312.86M7.41%
Mar 31, 20224.22B1.12B35.91%
Mar 31, 20213.11B76.62M2.53%
Mar 31, 20203.03B248.73M8.94%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

STE News

More News